DE69726716D1 - Antikachektische zusammensetzung - Google Patents

Antikachektische zusammensetzung

Info

Publication number
DE69726716D1
DE69726716D1 DE69726716T DE69726716T DE69726716D1 DE 69726716 D1 DE69726716 D1 DE 69726716D1 DE 69726716 T DE69726716 T DE 69726716T DE 69726716 T DE69726716 T DE 69726716T DE 69726716 D1 DE69726716 D1 DE 69726716D1
Authority
DE
Germany
Prior art keywords
pct
bond
substituted
ring
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69726716T
Other languages
English (en)
Other versions
DE69726716T2 (de
Inventor
Yu Momose
Etsuya Matsutani
Takashi Sohda
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Takeda Pharmaceutical Co Ltd
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Publication of DE69726716D1 publication Critical patent/DE69726716D1/de
Application granted granted Critical
Publication of DE69726716T2 publication Critical patent/DE69726716T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A61K31/422—Oxazoles not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/427—Thiazoles not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Bidet-Like Cleaning Device And Other Flush Toilet Accessories (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
  • Absorbent Articles And Supports Therefor (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
DE69726716T 1996-04-04 1997-04-03 Antikachektische zusammensetzung Expired - Lifetime DE69726716T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP8284596 1996-04-04
JP9027957A JPH09323930A (ja) 1996-04-04 1997-02-12 悪液質の予防・治療剤
PCT/JP1997/001148 WO1997037656A1 (en) 1996-04-04 1997-04-03 Anticachectic composition

Publications (2)

Publication Number Publication Date
DE69726716D1 true DE69726716D1 (de) 2004-01-22
DE69726716T2 DE69726716T2 (de) 2004-10-07

Family

ID=26365962

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69726716T Expired - Lifetime DE69726716T2 (de) 1996-04-04 1997-04-03 Antikachektische zusammensetzung

Country Status (7)

Country Link
US (2) US6110948A (de)
EP (1) EP0893995B1 (de)
JP (1) JPH09323930A (de)
AT (1) ATE255893T1 (de)
AU (1) AU2177997A (de)
DE (1) DE69726716T2 (de)
WO (1) WO1997037656A1 (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100290132B1 (ko) * 1994-07-01 2001-05-15 마이클 바마트 전신 염증 및 염증성 간염 치료용 피리미딘 누클레오티드 전구체
CA2311125C (en) 1997-11-19 2011-01-18 Takeda Chemical Industries, Ltd. Apoptosis inhibitor
EP0977753A1 (de) * 1997-12-02 2000-02-09 Dr. Reddy's Research Foundation Azolidinedione-derivate zur bekämpfung von diabetes, dislipämie und hypertonie
NZ333399A (en) * 1997-12-24 2000-05-26 Sankyo Co Cyclooxygenase-2 inhibitors (COX-2) for the prevention and treatment of tumors, cachexia and tumor-metastasis
US6897019B1 (en) * 1998-04-17 2005-05-24 Tufts College Methods for treating and preventing insulin resistance and related disorders
US7105552B2 (en) * 1998-05-08 2006-09-12 Theracos, Inc. Heterocyclic analogs of diphenylethylene compounds
US7407978B2 (en) * 1999-04-06 2008-08-05 Theracos, Inc. Heterocyclic analogs of diphenylethylene compounds
TWI249401B (en) 1999-04-14 2006-02-21 Takeda Chemical Industries Ltd Agent for improving ketosis
US20030087942A1 (en) * 2001-08-31 2003-05-08 Washington University Method for the treatment and prevention of cachexia
US20080114055A1 (en) * 2006-11-10 2008-05-15 Zoltan Laboratories Llc Thioxanthone Compounds to Reverse Weight Loss
US20080207738A1 (en) * 2007-02-28 2008-08-28 Cancure Laboratories, Llc Drug combinations to treat drug resistant tumors
WO2008144880A1 (en) * 2007-05-31 2008-12-04 F.P.L. Pharma Inc. Compositions for prevention or treatment of anorexia-cachexia syndrome and uses thereof
AU2008274941A1 (en) * 2007-07-12 2009-01-15 Tragara Pharmaceuticals, Inc. Methods and compositions for the treatment of cancer, tumors, and tumor-related disorders
IL294709B2 (en) * 2020-01-13 2023-07-01 Astromedical Biotechnology Ltd Use of ketamine in the treatment of exhaustion

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5522636A (en) * 1978-08-04 1980-02-18 Takeda Chem Ind Ltd Thiazoliding derivative
JPH06779B2 (ja) * 1985-06-10 1994-01-05 武田薬品工業株式会社 チアゾリジオン誘導体およびそれを含んでなる医薬組成物
TW268952B (de) * 1993-02-26 1996-01-21 Takeda Pharm Industry Co Ltd
GB9308487D0 (en) * 1993-04-23 1993-06-09 Smithkline Beecham Plc Novel compounds
US5478852C1 (en) * 1993-09-15 2001-03-13 Sankyo Co Use of thiazolidinedione derivatives and related antihyperglycemic agents in the treatment of impaired glucose tolerance in order to prevent or delay the onset of noninsulin-dependent diabetes mellitus
JP3029768B2 (ja) * 1994-04-18 2000-04-04 三共株式会社 悪液質改善剤
US6133278A (en) * 1994-08-12 2000-10-17 Takeda Chemical Industries, Ltd. Use of quinone and hydroquinone derivatives for the treatment of cachexia
TW403748B (en) * 1994-11-02 2000-09-01 Takeda Chemical Industries Ltd An oxazolidinedione derivative, its production and a pharmaceutical composition for lowering blood sugar and lipid in blood comprising the same

Also Published As

Publication number Publication date
ATE255893T1 (de) 2003-12-15
AU2177997A (en) 1997-10-29
EP0893995A1 (de) 1999-02-03
WO1997037656A1 (en) 1997-10-16
US6365607B1 (en) 2002-04-02
US6110948A (en) 2000-08-29
JPH09323930A (ja) 1997-12-16
DE69726716T2 (de) 2004-10-07
EP0893995B1 (de) 2003-12-10

Similar Documents

Publication Publication Date Title
DE69726716D1 (de) Antikachektische zusammensetzung
ES483311A1 (es) Un procedimiento para preparar derivados de prolina
IL146319A0 (en) Quinoline derivatives as inhibitors of mek enzymes
NZ507735A (en) Indole derivatives useful for treating malignant and other diseases caused by pathological cell proliferation
PL348769A1 (en) 4-oxo-1,4-dihydro-3-quinolinecarboxamides as antiviral agents
AU2910600A (en) Phenyl urea and phenyl thiourea derivatives
FR2672598B1 (de)
IL117875A0 (en) Pharmaceutical compositions for inhibiting th growth of cancers
ES2105617T3 (es) Derivados de piperacina como antagonistas de 5-ht.
ATE319680T1 (de) Substituierte 2-benzylamino-2-phenyl- acetamidverbindungen
NO990578L (no) Diesel-brennstoff inneholdende oksygenerte forbindelser
CA2247946A1 (en) Anticachectic composition
NZ333798A (en) Arylcycloalkane carboxylic esters, their use for the treatment of urinary incontinence or irritable bowel syndrome, and method of manufacture.
ES452649A1 (es) Un procedimiento para la preparacion de nuevas amidas cicli-cas.
ES2011075A6 (es) Procedimiento de obtencion de nuevas 3-(2-haloalquil)-1, 4-oxatiinas y2- (2-haloalquil) -1,4-ditiinas utiles en el tratamiento de leucemia y otros tumores.
ZA957449B (en) Bicyclic carboxamides
NZ513724A (en) Anticonvulsant derivatives useful in treating essential tremor
ES2017032A6 (es) Procedimiento para la obtencion de 4,5-dihidro-3(2h)-piridazinonas.
TR199701289T2 (xx) Karbapenemlerin esterleri
MX9709468A (es) Composiciones farmaceuticas para minimizar la perdida osea.
GR3006582T3 (de)
DE69511689D1 (de) Phosphonyldipeptide zur bekämpfung von kardiovasvakuläre erkrankungen

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: TAKEDA PHARMACEUTICAL CO. LTD., OSAKA, JP